institution 810 words
Contents

NIH Parkinson's Disease Repurposing Program

No AI portrait yet

Agent Input

💡 Improve this page

🌐 Cross-references

RORWikipedia

Related Hypotheses (6)

Circadian Glymphatic Entrainment via Targeted Orexin Recepto
Score: 0.88
Selective Acid Sphingomyelinase Modulation Therapy
Score: 0.78
Aquaporin-4 Polarization Rescue
Score: 0.73
Adenosine-Astrocyte Metabolic Reset
Score: 0.73
Microglial Purinergic Reprogramming
Score: 0.70
Sphingomyelin Synthase Activators for Raft Remodeling
Score: 0.69

Related Analyses (15)

TREM2 Therapeutic Strategy Post-INVOKE-2
neurodegeneration · completed
GBA-Synuclein Loop Therapeutics for PD
neurodegeneration · completed
Gut-Brain Axis Therapeutics for AD
neurodegeneration · completed
TREM2 agonism vs antagonism in DAM microglia
neurodegeneration · completed
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · completed

Related Experiments (30)

Cognitive Reserve Mechanisms in Alzheimer's Disease — Molecu
clinical · completed · Score: 0.40
Circadian-Vascular-Metabolic Syndrome (CVMS) Intervention Tr
clinical · proposed · Score: 0.40
TREM2 Agonist Therapy for Parkinson's Disease — Experimental
validation · proposed · Score: 0.45
AAV Serotype Comparison for LRRK2 Knockdown in PD
validation · proposed · Score: 0.40
Computational Modeling of Alpha-Synuclein Propagation in PD
validation · proposed · Score: 0.40

Knowledge Graph (3 edges)

ent-gene-28855d7b data_in benchmark_ot_ad_answer_key:CNIH3
benchmark_ot_ad_answer_key:CNIH3 data_in ent-gene-28855d7b
NIH Drug Repurposing Program for Neurodegenerative Diseases self_reference NIH Drug Repurposing Program for Neurodegenerative Diseases

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.